Page last updated: 2024-11-05

2,4-thiazolidinedione and Medulloblastoma

2,4-thiazolidinedione has been researched along with Medulloblastoma in 1 studies

thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.

Medulloblastoma: A malignant neoplasm that may be classified either as a glioma or as a primitive neuroectodermal tumor of childhood (see NEUROECTODERMAL TUMOR, PRIMITIVE). The tumor occurs most frequently in the first decade of life with the most typical location being the cerebellar vermis. Histologic features include a high degree of cellularity, frequent mitotic figures, and a tendency for the cells to organize into sheets or form rosettes. Medulloblastoma have a high propensity to spread throughout the craniospinal intradural axis. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2060-1)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Budassi, F1
Marchioro, C1
Canton, M1
Favaro, A1
Sturlese, M1
Urbinati, C1
Rusnati, M1
Romagnoli, R1
Viola, G1
Mariotto, E1

Other Studies

1 other study available for 2,4-thiazolidinedione and Medulloblastoma

ArticleYear
Design, synthesis and biological evaluation of novel 2,4-thiazolidinedione derivatives able to target the human BAG3 protein.
    European journal of medicinal chemistry, 2023, Dec-05, Volume: 261

    Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; Ce

2023